The development of DNA vaccines against SARS-CoV-2.

Authors:
Khalid K; Poh CL.

Journal:
Adv Med Sci

Publication Year: 2023

DOI:
10.1016/j.advms.2023.05.003

PMCID:
PMC10290423

PMID:
37364379

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Adv Med Sci

Abbreviation: Adv Med Sci

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Medicine

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Inflammatory and thrombotic parameters associated with the COVID-19 course in Poland (SARSTer study…
Czupryna P; Moniuszko-Malinowska A; Rogalska M and 22 more (2022) - Transparency Score: 3/6
Cardiac injury and COVID-19 associated coagulopathy in patients with acute SARS-CoV-2 pneumonia: A …
Capone F; Cipriani A; Molinari L and 10 more (2021) - Transparency Score: 2/6
Lung ultrasound in the diagnosis of COVID-19 infection - A case series and review of the literature.
Buda N; Segura-Grau E; Cylwik J and 1 more (2020) - Transparency Score: 1/6
The clinical applications of a multigene liquid biopsy (NETest) in neuroendocrine tumors.
Malczewska A; Kos-Kudła B; Kidd M and 5 more (2019) - Transparency Score: 2/6
View All Papers from This Journal
Transparency Score
2/6
33.3% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Financial disclosure The authors have no funding to disclose. Declaration of competing interest The authors declare no conflict of interests."

Funding Disclosure
Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025